Solid Biosciences Inc. SLDB Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| —— | —— | —— | $8.09M-40.6% | ||
| $140.33M+45.5% | $96.43M+25.9% | $76.56M-2.4% | $78.42M+33.5% | ||
| $38.88M+16.8% | $33.3M+20.0% | $27.75M-4.1% | $28.95M+6.7% | ||
| $179.21M+38.1% | $129.73M+24.4% | $104.25M-9.0% | $114.55M+33.4% | ||
| -$179.21M-38.1% | -$129.73M-24.4% | -$104.25M+2.1% | -$106.45M-47.3% | ||
| -$208K-161% | $340K-22.6% | $439K— | —— | ||
| $5.27M— | —— | $8.24M-59.8% | $20.47M+30,917% | ||
| -$174.33M-39.8% | -$124.7M-29.9% | -$96.02M-11.7% | -$85.98M-19.1% | ||
| -$2.02+34.0% | -$3.06+36.8% | -$4.84+52.0% | -$10.09-93.3% | ||
| -$177.57M-39.5% | -$127.27M-25.2% | -$101.67M+2.3% | -$104.04M-50.2% | ||
| -$179.21M-38.1% | -$129.73M-24.4% | -$104.25M+2.1% | -$106.45M-47.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Solid Biosciences Inc.'s revenue?
- Solid Biosciences Inc. (SLDB) generated $8.1M in revenue over the trailing twelve months, down 40.6% year over year.
- Is Solid Biosciences Inc. profitable?
- Solid Biosciences Inc. is not currently profitable: it reported a net loss of $191.8M over the trailing twelve months, a -1062.3% net margin.
- What is Solid Biosciences Inc.'s earnings per share?
- Solid Biosciences Inc.'s diluted EPS over the trailing twelve months is $-1.95.
- Where does Solid Biosciences Inc.'s income statement data come from?
- Every line is extracted from Solid Biosciences Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
